These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2547379)

  • 41. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
    Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
    Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibitory effects of kynurenic acid, a tryptophan metabolite, and its derivatives on cytosolic sulfotransferases.
    Senggunprai L; Yoshinari K; Yamazoe Y
    Biochem J; 2009 Aug; 422(3):455-62. PubMed ID: 19548878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kynurenic acid synthesis by human glioma.
    Vezzani A; Gramsbergen JB; Versari P; Stasi MA; Procaccio F; Schwarcz R
    J Neurol Sci; 1990 Oct; 99(1):51-7. PubMed ID: 2250171
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kynurenic acid synthesis in cerebral cortical slices of rats with progressing symptoms of thioacetamide-induced hepatic encephalopathy.
    Saran T; Hilgier W; Urbańska EM; Turski WA; Albrecht J
    J Neurosci Res; 2004 Feb; 75(3):436-40. PubMed ID: 14743457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of kynurenic acid levels in the developing rat brain.
    Schwarcz R; Poeggeler B; Rassoulpour A; Ceresoli-Borroni G; Hodgkins PS
    Amino Acids; 1998; 14(1-3):243-9. PubMed ID: 9871469
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relevance of Alternative Routes of Kynurenic Acid Production in the Brain.
    Ramos-Chávez LA; Lugo Huitrón R; González Esquivel D; Pineda B; Ríos C; Silva-Adaya D; Sánchez-Chapul L; Roldán-Roldán G; Pérez de la Cruz V
    Oxid Med Cell Longev; 2018; 2018():5272741. PubMed ID: 29977455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alteration of kynurenic acid concentration in rat plasma following optically pure kynurenine administration: a comparative study between enantiomers.
    Fukushima T; Sone Y; Mitsuhashi S; Tomiya M; Toyo'oka T
    Chirality; 2009 Apr; 21(4):468-72. PubMed ID: 18655158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kynurenate and 7-chlorokynurenate formation in chronically epileptic rats.
    Wu HQ; Rassoulpour A; Goodman JH; Scharfman HE; Bertram EH; Schwarcz R
    Epilepsia; 2005 Jul; 46(7):1010-6. PubMed ID: 16026552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased concentration of cerebral kynurenic acid alters stimulus processing and conditioned responding.
    Chess AC; Bucci DJ
    Behav Brain Res; 2006 Jun; 170(2):326-32. PubMed ID: 16621049
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kynurenic acid and its analogue can alter the opioid receptor G-protein signaling after acute treatment via NMDA receptor in rat cortex and striatum.
    Samavati R; Zádor F; Szűcs E; Tuka B; Martos D; Veres G; Gáspár R; Mándity IM; Fülöp F; Vécsei L; Benyhe S; Borsodi A
    J Neurol Sci; 2017 May; 376():63-70. PubMed ID: 28431630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kynurenic acid inhibits the release of the neurotrophic fibroblast growth factor (FGF)-1 and enhances proliferation of glia cells, in vitro.
    Di Serio C; Cozzi A; Angeli I; Doria L; Micucci I; Pellerito S; Mirone P; Masotti G; Moroni F; Tarantini F
    Cell Mol Neurobiol; 2005 Sep; 25(6):981-93. PubMed ID: 16392031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kynurenic acid distribution into brain and peripheral tissues of mice.
    Lou GL; Pinsky C; Sitar DS
    Can J Physiol Pharmacol; 1994 Feb; 72(2):161-7. PubMed ID: 8050057
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electrophysiological characterisation of the actions of kynurenic acid at ligand-gated ion channels.
    Mok MH; Fricker AC; Weil A; Kew JN
    Neuropharmacology; 2009 Sep; 57(3):242-9. PubMed ID: 19523966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for intraocular synthesis of kynurenic acid, a putative endogenous neuroprotectant.
    Zarnowski T; Rejdak R; Zagórski Z; Kocki T; Kleinrok Z; Turski WA
    Ophthalmic Res; 2001; 33(2):107-10. PubMed ID: 11244357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Micromolar brain levels of kynurenic acid are associated with a disruption of auditory sensory gating in the rat.
    Shepard PD; Joy B; Clerkin L; Schwarcz R
    Neuropsychopharmacology; 2003 Aug; 28(8):1454-62. PubMed ID: 12700696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid.
    Erhardt S; Engberg G
    Acta Physiol Scand; 2002 May; 175(1):45-53. PubMed ID: 11982504
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electrophysiological effects of exogenous and endogenous kynurenic acid in the rat brain: studies in vivo and in vitro.
    Scharfman HE; Goodman JH; Schwarcz R
    Amino Acids; 2000; 19(1):283-97. PubMed ID: 11026500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
    Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
    Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prolonged nicotine administration results in biphasic, brain-specific changes in kynurenate levels in the rat.
    Rassoulpour A; Wu HQ; Albuquerque EX; Schwarcz R
    Neuropsychopharmacology; 2005 Apr; 30(4):697-704. PubMed ID: 15496939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. On the toxicity of kynurenic acid in vivo and in vitro.
    Turski WA; Małaczewska J; Marciniak S; Bednarski J; Turski MP; Jabłoński M; Siwicki AK
    Pharmacol Rep; 2014 Dec; 66(6):1127-33. PubMed ID: 25443745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.